Position in DCTH
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,082,110
+$933,018 QoQ
Shares Held
85,950
+435.0% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#34
of 119 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DCTH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,693,166 across 42 Medical Devices names. DCTH ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in DCTH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,082,110 | 85,950 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $149,092 | 16,066 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $684,557 | 67,778 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $933,789 | 68,661 | Shares | Sole | 2025-07-22 | |
| 2024-12-31 | $130,634 | 10,850 | Shares | Sole | 2025-02-07 | |
| 2023-09-30 | $63,139 | 15,590 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||